Breaking: Suspected Marburg Virus Outbreak in Tanzania – WHO Issues Alert

on
January 16, 2025

Nine suspected cases of Marburg Virus Disease (MVD), including eight deaths, were reported in Tanzania’s Kagera region. The outbreak spans two districts, Biharamulo and Muleba and presents a high case fatality rate (CFR) of 89%. WHO has issued a rapid alert to its Member States, highlighting the urgent need for enhanced surveillance and medical response.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, stated: “The suspected outbreak underscores the critical importance of preparedness and rapid response in preventing the spread of deadly diseases.”

Key Findings

Symptoms: Patients presented with high fever, headaches, diarrhoea, hematemesis and external haemorrhage. Healthcare workers are among the suspected cases, raising concerns about nosocomial transmission.

High Risk: The outbreak coincides with the Kagera region’s status as a transit hub with cross-border connections to Uganda, Rwanda, Burundi, and the Democratic Republic of Congo.

Potential Spread: While the global risk is low, regional risk remains high due to delayed case isolation and ongoing cross-border movement.

Public Health Response

• National rapid response teams have been deployed for outbreak investigation and contact tracing.

• Mobile laboratories and isolation units have been established in the affected districts.

• WHO advises strict infection prevention protocols, including the use of personal protective equipment (PPE), safe burial practices, and active case surveillance.

Advice for Medical Professionals

Doctors are urged to:

• Screen patients presenting with MVD-compatible symptoms.

• Report suspected cases promptly and ensure proper isolation measures.

• Implement WHO infection prevention and control (IPC) guidelines to minimize healthcare-associated infections.

Global Context

This is the second MVD outbreak in the region within two years; the 2023 outbreak involved nine cases and six deaths. No licensed vaccines exist yet, though experimental candidates are under investigation. WHO calls for strengthened readiness and cross-border coordination to mitigate further risks.

For full WHO recommendations and updates, visit WHO Marburg Virus Advisory.

Doctors worldwide are encouraged to remain vigilant, especially those in high-risk zones or treating patients from affected areas. Early detection and robust IPC measures can significantly mitigate the disease’s spread.